Medicinal composition for treating B cell lymph tumour

A composition and a technology for lymphoma, which are applied in the field of pharmaceutical compositions for treating cancer, can solve the problems of expensive treatment costs and drug resistance of patients, and achieve the effects of reducing costs and improving curative effects.
CN1824307AInactive Publication Date: 2006-08-30RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
0 Cites 5 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
Publication Date
2006-08-30
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

A composite medicine for treating B-cell leucoma is prepared from rituximab and suberoylanilide hydroxamic acid (SAHA). Its advantages are obvious synergistic effect, high curative effect and low cost.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a pharmaceutical composition for treating cancer, in particular to a pharmaceutical composition for treating B-cell lymphoma. Background technique

[0002] Lymphoma is a kind of malignant tumor originating from lymphoid tissue. In recent years, the worldwide incidence rate has almost doubled, seriously endangering human health. B-cell lymphoma is the most common type of lymphoma, accounting for about 50-60% of lymphomas. Except for early-stage, localized, and low-grade B-cell lymphoma, which can be treated with radiotherapy alone, the current main treatment method is still combined chemotherapy. Combined chemotherapy can make about 50-60% of patients achieve disease remission, and 20-30% of patients achieve long-term survival, but most patients are ineffective or relapse rapidly after treatment, the disease progresses rapidly, and the prognosis is poor. More importantly, the side effects of chemotherapy are large, and patient...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More